ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Veterinary Regenerative Medicine

Volume 12 - 2025 | doi: 10.3389/fvets.2025.1579790

Integrative metabolomics and proteomics reveal the effects and mechanisms of Salvia miltiorrhiza in alleviating traumatic blood stasis syndrome

Provisionally accepted
  • 1Nanjing Agricultural University, Nanjing, Jiangsu Province, China
  • 2Qingdao Agricultural University, Qingdao, Shandong Province, China

The final, formatted version of the article will be published soon.

Salvia miltiorrhiza (SM) is widely used in clinical practice for the treatment of cardiovascular diseases. However, the efficacy and mechanisms of SM in addressing traumatic blood stasis syndrome (TBSS) have not been thoroughly investigated. We established a TBSS model in cats and examined the muscle swelling rate (MSR), pain index, coagulation index, hematological parameters, inflammatory factors, and platelet function levels to assess the effects of SM. Subsequently, integrative metabolomics and proteomics were employed to elucidate the effects and mechanisms of SM in alleviating TBSS. The results demonstrate that the effect of SM was evaluated by establishing a cat model of TBSS. Administration of SM for 10 days effectively mitigated the significant increase in markers such as MSR, pain index, WBC, PLT, PCT, FIB, PAI-1, TNF-α, IL-6, IL-1β, TBX2, TXB2/6-Keto-PGF1α, β-TG, and PF4. Additionally, there was a significant decrease in APTT, PT, TT, t-PA, IL-10, 6-Keto-PGF1α, and FN. These findings suggest that SM regulates swelling and pain, inflammatory responses, coagulation and fibrinolytic system abnormalities, as well as platelet aggregation and activation. Through platelet metabolomic and proteomic analyses, it was found that SM inhibited the aggregation and activation processes of TBSS platelets by modulating physiological pathways, including tryptophan metabolism, purine metabolism, fatty acid metabolism, the complement and coagulation cascades, and platelet activation.

Keywords: Salvia miltiorrhiza, traumatic blood stasis syndrome, Platelet, Proteomics, Metabolomics

Received: 20 Feb 2025; Accepted: 07 Apr 2025.

Copyright: © 2025 Pei, Xin, Xufeng, Liu and Zhihua. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Jiaguo Liu, Nanjing Agricultural University, Nanjing, 210095, Jiangsu Province, China
Qin Zhihua, Qingdao Agricultural University, Qingdao, Shandong Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more